Alpha 2.0
Login Register
» Authors » Sebastien Maury

Sebastien Maury

Explore the profile of Sebastien Maury including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 2306
Followers 0
Related Specialties
Hematology
Oncology
General Surgery
Top 10 Co-Authors
Mathieu Leclerc
Catherine Cordonnier
Cecile Pautas
Patrice Chevallier
Rabah Redjoul
Florence Beckerich
Gerard Socie
Jose L Cohen
Christine Robin
Anne Huynh
Published In
Haematologica
Blood
Biol Blood Marrow Transplant
Bone Marrow Transplant
Am J Hematol
Affiliations
Soon will be listed here.
Recent Articles
1.
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid Leukemia: A Report From the RESIDIAG Study
Guerineau H, Cayuela J, Dulucq S, Tran Quang V, Tarfi S, Gricourt G, et al.
Am J Hematol . 2024 Dec; 100(3):507-510. PMID: 39654506
No abstract available.
2.
Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry
Rabian F, Beauvais D, Marchand T, Furst S, Huynh A, Brissot E, et al.
Blood Adv . 2024 Aug; 8(21):5493-5496. PMID: 39207868
No abstract available.
3.
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT
Mohty R, Bazarbachi A, Labopin M, Esteve J, Kroger N, Cornelissen J, et al.
Bone Marrow Transplant . 2024 Aug; 59(11):1534-1541. PMID: 39143183
Isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) mutations have uncertain prognostic implications in AML. We investigate the impact IDH1 and IDH2 mutations in AML patients undergoing allogeneic hematopoietic cell...
4.
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome-Positive ALL: A GRAAPH-2014 Study
Kim R, Chalandon Y, Rousselot P, Cayuela J, Huguet F, Balsat M, et al.
J Clin Oncol . 2024 Jul; 42(26):3140-3150. PMID: 39028928
Purpose: quantification is widely regarded as the standard for monitoring measurable residual disease (MRD) in Philadelphia chromosome-positive (Ph+) ALL. However, recent evidence of multilineage involvement questions the significance of MRD....
5.
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT
Ye Y, Labopin M, Chen J, Wu D, Gedde-Dahl Sr T, Blaise D, et al.
Blood Cancer J . 2024 May; 14(1):85. PMID: 38802349
No abstract available.
6.
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients
Leroyer E, Petitpain N, Morisset S, Neven B, Castelle M, Winter S, et al.
Hemasphere . 2024 Mar; 8(1):e40. PMID: 38434523
No abstract available.
7.
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry
Lacan C, Lambert J, Forcade E, Robin M, Chevallier P, Loron S, et al.
J Hematol Oncol . 2024 Jan; 17(1):2. PMID: 38185663
The use of peripheral blood (PB) or bone marrow (BM) stem cells graft in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis remains controversial....
8.
Long-term outcome after autologous -negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia: a comparative study
Caillot L, Leclerc M, Sleiman E, Sloma I, Wagner-Ballon O, Claudel A, et al.
Haematologica . 2023 Nov; 109(4):1264-1268. PMID: 38031800
No abstract available.
9.
Treg-targeted IL-2/anti-IL-2 complex controls graft--host disease and supports anti-tumor effect in allogeneic hematopoietic stem cell transplantation
Thiolat A, Pilon C, Caudana P, Moatti A, To N, Sedlik C, et al.
Haematologica . 2023 Sep; 109(1):129-142. PMID: 37706355
Modulating an immune response in opposite directions represents the holy grail in allogeneic hematopoietic stem cell transplantation (allo-HSCT) to avoid insufficient reactivity of donor T cells and hematologic malignancy relapse...
10.
Divergent CD4 T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients
Khelfa M, Leclerc M, Kerbrat S, Boudjemai Y, Benchouaia M, Neyrinck-Leglantier D, et al.
Front Immunol . 2023 Sep; 14:1165973. PMID: 37701444
Introduction: Acute myeloid leukemia (AML) is one of the commonest hematologic disorders. Due to the high frequency of disease- or treatment-related thrombocytopenia, AML requires treatment with multiple platelet transfusions, which...